Niadyne Pharma, Inc. (NPI), located in Fort Worth, Texas is involved in the discovery and development
of uniquely efficacious molecules to prevent and treat skin conditions that result from an impaired skin barrier.
Technology developed by Niadyne Pharma is currently present in cosmeceutical photodamage repair
skin care products that include the NIA24 line of products.
Ongoing product development is focused on pharmaceutical products for prevention
and treatment of conditions with skin barrier impairment that include pre-cancerous actinic keratosis lesions, psoriasis,
acne, rosacea, atopic dermatitis, side effects of widely used dermatology drugs such as topical retinoids and steroids as
well as cancer chemotherapeutic drugs.